<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03171129</url>
  </required_header>
  <id_info>
    <org_study_id>5160055</org_study_id>
    <nct_id>NCT03171129</nct_id>
  </id_info>
  <brief_title>ADINA vs. High Flow Nasal Cannula Comparison Study</brief_title>
  <official_title>Adaptive Dynamic Inspiratory Nasal Apparatus (ADINA): Comparison to High Flow Nasal Cannula (HFNC)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Loma Linda University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Loma Linda University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_unapproved_device>No</is_unapproved_device>
    <is_ppsd>No</is_ppsd>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is to evaluate the feasibility of using a pressure limited nasal cannula system
      instead of a high flow nasal cannula system in the management of premature babies with
      respiratory distress.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      NCPAP has been used increasingly to manage respiratory distress in newborns as well as apnea
      of prematurity. Humidified high flow nasal cannula devices (flows 1-8 lpm) have also been
      used in neonatal intensive care units.

      This study is to evaluate the feasibility of using a pressure limited nasal cannula system
      instead of a high flow nasal cannula system in the management of premature babies with
      respiratory distress.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">July 2018</start_date>
  <completion_date type="Anticipated">July 2019</completion_date>
  <primary_completion_date type="Anticipated">July 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Duration of Oxygen Use</measure>
    <time_frame>From time of randomization until time of discharge from the Neonatal Intensive Care Unit (NICU) up to 100 days.</time_frame>
    <description>The length of time the patient is on oxygen will be measured in hours.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Oxygen Concentration</measure>
    <time_frame>From time of randomization until time of discharge from NICU up to 100 days.</time_frame>
    <description>ADINA will provide a concentration of oxygen between 1.5 and 4 liters which is equivalent to that provided by the conventional nasal cannula. This will be measured every twelve hours by NICU staff.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants with treatment-related pneumothorax</measure>
    <time_frame>From time of randomization until time of discharge from NICU up to 100 days.</time_frame>
    <description>Participants will be monitored for pneumothorax occurrence while on ADINA and/or high flow nasal cannula. The incidence of pneumothorax occurrence in each Arm will be collected for comparison.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants with Excoriation at Nasal Site</measure>
    <time_frame>From time of randomization until time of discharge from NICU up to 100 days.</time_frame>
    <description>Participants will be monitored for excoriation at the nasal site while on ADINA and/or high flow nasal cannula. The incidence of excoriation at the nasal site in each Arm will be collected for comparison.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Respiratory Distress Neonatal</condition>
  <arm_group>
    <arm_group_label>High flow nasal cannula system w/ ADINA</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The intervention is the insertion of the the ADINA device into the high flow nasal cannula system. ADINA will be placed according to weight class recommendations to increase the positive end expiratory pressure (PEEP). ADINA is actually a combination of the Neotech RAM Cannula and a clear Regulator/Pop off valve.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>high flow nasal cannula system</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>High flow nasal cannula will deliver oxygen at 2-4 lpm of flow. High flow cannula are used to provide the control interface.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Adaptive Dynamic Inspiratory Nasal Apparatus</intervention_name>
    <description>Oxygen will be administered via ADINA</description>
    <arm_group_label>High flow nasal cannula system w/ ADINA</arm_group_label>
    <other_name>ADINA</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>High flow Nasal Canula</intervention_name>
    <description>Oxygen will be administered via nasal canula</description>
    <arm_group_label>high flow nasal cannula system</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Neonates admitted to NICU

          -  Weights of 400-500 grams

          -  Requiring oxygen greater than 30%

          -  No evidence of focal lobar consolidation in lung fields

        Exclusion Criteria:

          -  Intolerance to procedure

          -  gelatinous skin

          -  known allergy to adhesive material

          -  interference with therapy

          -  profound sepsis

          -  pneumonia

          -  unmanaged apnea/bradycardia

          -  known or suspect complex congenital heart disease

          -  severe cleft lip or palate

          -  suspect or proven lethal congenital anomaly

          -  intolerance to the interface used in the devices

          -  inability to secure an appropriate fit of the patient nasal interface

          -  considered non-viable or of uncertain viability

          -  parental refusal.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>23 Weeks</minimum_age>
    <maximum_age>40 Weeks</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mitchell R Goldstein, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Loma Linda University Health</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>John R Loor, BS</last_name>
    <phone>909-558-5830</phone>
    <email>JLoor@llu.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Melissa Rundquist</last_name>
    <phone>909-558-5830</phone>
    <email>MRundquist@llu.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Loma Linda University Medical Center</name>
      <address>
        <city>Loma Linda</city>
        <state>California</state>
        <zip>92354</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Gregory GA, Kitterman JA, Phibbs RH, Tooley WH, Hamilton WK. Treatment of the idiopathic respiratory-distress syndrome with continuous positive airway pressure. N Engl J Med. 1971 Jun 17;284(24):1333-40.</citation>
    <PMID>4930602</PMID>
  </reference>
  <reference>
    <citation>Dutta S. High-flow nasal cannula versus nasal continuous positive airway pressure in the management of apnea of prematurity. Pediatrics. 2002 Apr;109(4):718-9; author reply 718-9.</citation>
    <PMID>11927724</PMID>
  </reference>
  <reference>
    <citation>Campbell DM, Shah PS, Shah V, Kelly EN. Nasal continuous positive airway pressure from high flow cannula versus Infant Flow for Preterm infants. J Perinatol. 2006 Sep;26(9):546-9. Epub 2006 Jul 13.</citation>
    <PMID>16837929</PMID>
  </reference>
  <reference>
    <citation>Kubicka ZJ, Limauro J, Darnall RA. Heated, humidified high-flow nasal cannula therapy: yet another way to deliver continuous positive airway pressure? Pediatrics. 2008 Jan;121(1):82-8. doi: 10.1542/peds.2007-0957.</citation>
    <PMID>18166560</PMID>
  </reference>
  <reference>
    <citation>Woodhead DD, Lambert DK, Clark JM, Christensen RD. Comparing two methods of delivering high-flow gas therapy by nasal cannula following endotracheal extubation: a prospective, randomized, masked, crossover trial. J Perinatol. 2006 Aug;26(8):481-5. Epub 2006 May 25.</citation>
    <PMID>16724119</PMID>
  </reference>
  <reference>
    <citation>Shoemaker MT, Pierce MR, Yoder BA, DiGeronimo RJ. High flow nasal cannula versus nasal CPAP for neonatal respiratory disease: a retrospective study. J Perinatol. 2007 Feb;27(2):85-91.</citation>
    <PMID>17262040</PMID>
  </reference>
  <reference>
    <citation>Sreenan C, Lemke RP, Hudson-Mason A, Osiovich H. High-flow nasal cannulae in the management of apnea of prematurity: a comparison with conventional nasal continuous positive airway pressure. Pediatrics. 2001 May;107(5):1081-3.</citation>
    <PMID>11331690</PMID>
  </reference>
  <reference>
    <citation>Centers for Disease Control and Prevention (CDC). Update: Ralstonia species associated with Vapotherm oxygen delivery devices--United States, 2005. MMWR Morb Mortal Wkly Rep. 2005 Nov 4;54(43):1104-5.</citation>
    <PMID>16267498</PMID>
  </reference>
  <reference>
    <citation>Centers for Disease Control and Prevention (CDC). Ralstonia associated with Vapotherm oxygen delivery device--United States, 2005. MMWR Morb Mortal Wkly Rep. 2005 Oct 21;54(41):1052-3.</citation>
    <PMID>16237377</PMID>
  </reference>
  <verification_date>May 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 25, 2017</study_first_submitted>
  <study_first_submitted_qc>May 26, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">May 31, 2017</study_first_posted>
  <last_update_submitted>May 2, 2018</last_update_submitted>
  <last_update_submitted_qc>May 2, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 3, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Respiratory Distress</keyword>
  <keyword>Nasal CPAP</keyword>
  <keyword>high flow nasal canula</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

